Due to ongoing labour disputes, Canada Post services will be suspended, which may impact some of our FIT and Integrative Laboratory Services (ILS) clients. Read more
Back to Test Catalogue

Heparin – Fondaparinux, Plasma

Test ID: HEPFONDA
Test
Specimen
Performance / Interpretation
Interface / Setup

Test

Aliases/Synonyms

Arixtra

Method

Chromogenic

Platform

STA-R Analyzer

Report Includes

Heparin - Fondaparinux

Specimens

Plasma (Na Citrate)

Test Location

Laboratory Reference Centre, 237 Barton Street E, Hamilton ON L8L 2X2

Test Version

8-Jun-2023

Specimen

Specimens

Plasma (Na Citrate)

Sample Volume

1 mL

Collection & Handling

Handling Information

Prepare platelet poor plasma. Separate and freeze immediately. Store and send frozen.

Rejection Criteria

Specimen Not frozen

Test Version

8-Jun-2023

Performance / Interpretation

Method

Chromogenic

Platform

STA-R Analyzer

Turnaround Time

3 days

Results

Name Units Reference Range Conversion Factor
Heparin - Fondaparinux U/mL
  • A therapeutic range for Fondaparinux has not been established. Average peak, steady-state levels (2 - 3 hours post-dose) of approximately 1.02-1.07 IU anti-Xa activity/mL have been reported for patients given therapeutic doses of Fondaparinux for symptomatic DVT/PE.

Test Location

Laboratory Reference Centre, 237 Barton Street E, Hamilton ON L8L 2X2

Test Version

8-Jun-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
HEPFONA 28134HEP 10A - FONDA U/mL

Test Version

8-Jun-2023